April 24, 2014

As part of the launch of DSN’s new microsite, DrugStoreNews.com/Pain-Management, DSN had the opportunity to speak with Carmen Catizone, executive director of the National Association of Boards of Pharmacy, regarding a new initiative that the association is spearheading to address the current patient access problem when it comes to pain management pharmaceuticals.

January 23, 2014

In a recent report, 59News explored how DEA regulations on pain medications can limit a pharmacy's supply, preventing patients from obtaining their medications.

January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

January 2, 2014

One reason pain patient advocates are so passionate about what they do is because they are pain patients themselves — they know the stigma associated with chronic pain; they know how difficult it can be to access appropriate pain therapy sometimes. That’s the story of Gina Libby, volunteer pain patient advocate who has lived with chronic pain for more than 20 years.

July 17, 2014

Purdue Pharma announced that the Food and Drug Administration approved a new 7.5-mcg/hour dosage strength of Butrans (buprenorphine) transdermal system CIII.

July 10, 2014

While sales of heat and ice packs are relatively flat — the category generated slight growth of 0.2% to $235.9 million for the 52 weeks ended April 20 across total U.S. multi-outlets, according to IRI — there has been some positive momentum within the category.

July 8, 2014

NeuroMetrix on Tuesday announced that its wearable technology for treatment of chronic pain received 510(k) clearance from the Food and Drug Administration for over-the-counter use.

June 26, 2014

The Acetaminophen Awareness Coalition on Thursday released “Acetaminophen: How It’s Used, Preventing Overdose and What We Can Do to Promote Safe Use,” a report and educational resource to drive safe and appropriate use of one of the United States’ most common drug ingredients.

June 12, 2014

Carex Health Brands on Thursday introduced AccuRelief Pain Relief Systems, a line of transcutaneous electrical nerve stimulation (TENS) therapy FDA–approved for full-body, over–the–counter use.

June 10, 2014

McNeil Consumer Healthcare on Monday announced the launch of Stories of Strength, a program that encourages people to honor someone who has been a source of strength in their lives.

June 1, 2014

Suppliers are given the opportunity to showcase their products for retail buyers at the GMDC Health, Beauty and Wellness Marketing Conference. Below, Drug Store News highlights some of the hot OTC products in the showcase this year.

May 20, 2014

Tiger Balm U.S. has formalized an endorsement deal with professional flatland BMX rider Terry Adams, the company announced Tuesday.

May 19, 2014

The American Podiatric Medical Association on Monday reported that while 77% of Americans experienced foot pain, only a third of them sought care from a podiatrist.

May 14, 2014

Tiger Balm U.S. on Wednesday announced its third year as a premier sponsor of the Avon Walk for Breast Cancer Chicago.

May 1, 2014

Purdue Pharma on Wednesday announced that it filed a new drug application with the Food and Drug Administration to market a hydrocodone bitartrate tablet, which is formulated to incorporate abuse-deterrent technology.

April 24, 2014

End CHRONIC PAIN! Corydalis Pain Relief Herb Pack is the newest product from the oldest Eastern herbal medicine traditions. Use it for headaches, back aches, arthritic pain and even nerve problems and muscle spasms.

April 21, 2014

ABC News will be hosting a live twitter chat focusing on pain management on Tuesday, April 22, at 1 p.m., as part of the news agency's next ABC News National Tweet Chat.

April 9, 2014

GM Pharmaceuticals recently announced the addition of 8-oz. bottles to its line of liquid pain relief VanaPain.

March 28, 2014

DSN recently launched a new microsite, DrugStoreNews.com/Pain-Management, to bring attention to a tragic side of the prescription drug abuse story — one that's not often told. The millions of Americans who live in chronic pain who already find it difficult to access the medications they need may soon find it even more difficult — because proposed changes in regulatory policy are expected to place additional hurdles on their treatment pathway.

March 27, 2014

A study from Wahl Therapeutic Massagers released Thursday found that physical aches and soreness are a real threat to travelers of all ages — 92% of adults 18 years of age and older experience physical pain while traveling.

March 25, 2014

The Drug Store News Group, the leading provider of news, information and clinical education for the retail pharmacy industry, has launched the new microsite, Drugstorenews.com/pain-management, to help bring attention to another tragic side of the prescription drug abuse story — the millions of Americans who live in chronic pain that may be unable to access the medications they need thanks to proposed changes in regulatory policy.

March 25, 2014

VR1 on Tuesday announced the availability of Ausanil, a new non-prescription homeopathic nasal spray formulated to provide rapid pain relief from severe headaches and migraines with no reported systemic side effects or adverse drug-drug interactions.

March 20, 2014

Purdue Pharma recently announced that a Phase 3 study of an investigational extended‐release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once‐daily analgesic agent experienced statistically significant reduction in pain compared with placebo.

March 18, 2014

Mallinckrodt Plc last week announced that the Food and Drug Administration approved Xartemis XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII), for the management of acute pain severe enough that it requires opioid treatment.